Diagnosis and Management of Retinal Vasoproliferative Tumors

• by Arun D. Singh, MD, Soumaya Bouhout, MD

• September 1, 2025

Why Uveitis Fellowship Deserves a Second Look

Uveitis Corner: Survey data and specialist insights challenge long-standing misconceptions about uveitis training, surgery, and compensation.

• by John A. Gonzales, MD , Jessica Shantha, MD, Sruthi Arepalli, MD, Edmund Tsui, MD, Paulina Liberman, MD, Meghan Berkenstock, MD

• March 1, 2026

• 6 min

Imaging Leukocyte Dynamics in Retinal Disease

The movement of immune cells through the retinal vasculature has long been inferred from laboratory models. Now, advances in imaging are allowing clinicians to observe these processes directly. At the 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Denver, Richard B. Rosen, MD, ScD(hon), FACS, FASRS, FARVO, described early clinical work using adaptive optics scanning laser ophthalmoscopy (AOSLO) to visualize leukocyte trafficking in vivo.

• by Jim Gallagher, senior managing editor

• May 1, 2026

• 4 min

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

• by Kerri Miller

• May 7, 2026

• 3 min